161 related articles for article (PubMed ID: 34865304)
21. Gestational weight gain during the second and third trimesters and adverse pregnancy outcomes, results from a prospective pregnancy cohort in urban Tanzania.
Yang J; Wang M; Tobias DK; Rich-Edwards JW; Darling AM; Abioye AI; Pembe AB; Madzorera I; Fawzi WW
Reprod Health; 2022 Jun; 19(1):140. PubMed ID: 35710384
[TBL] [Abstract][Full Text] [Related]
22. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.
Fornes R; Simin J; Nguyen MH; Cruz G; Crisosto N; van der Schaaf M; Engstrand L; Brusselaers N
Reprod Biol Endocrinol; 2022 Feb; 20(1):30. PubMed ID: 35130922
[TBL] [Abstract][Full Text] [Related]
24. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study.
Vanky E; Stridsklev S; Heimstad R; Romundstad P; Skogøy K; Kleggetveit O; Hjelle S; von Brandis P; Eikeland T; Flo K; Berg KF; Bunford G; Lund A; Bjerke C; Almås I; Berg AH; Danielson A; Lahmami G; Carlsen SM
J Clin Endocrinol Metab; 2010 Dec; 95(12):E448-55. PubMed ID: 20926533
[TBL] [Abstract][Full Text] [Related]
25. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract][Full Text] [Related]
26. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
Moran LJ; Meyer C; Hutchison SK; Zoungas S; Teede HJ
J Endocrinol Invest; 2010 Apr; 33(4):258-65. PubMed ID: 19834313
[TBL] [Abstract][Full Text] [Related]
27. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.
Palomba S; Falbo A; Russo T; Manguso F; Tolino A; Zullo F; De Feo P; Orio F
J Clin Endocrinol Metab; 2007 Aug; 92(8):3128-35. PubMed ID: 17519312
[TBL] [Abstract][Full Text] [Related]
28. Circulating ghrelin levels in patients with polycystic ovary syndrome.
Schöfl C; Horn R; Schill T; Schlösser HW; Müller MJ; Brabant G
J Clin Endocrinol Metab; 2002 Oct; 87(10):4607-10. PubMed ID: 12364442
[TBL] [Abstract][Full Text] [Related]
29. The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
Cakiroglu Y; Vural B; Isgoren S
Arch Gynecol Obstet; 2013 Jul; 288(1):213-20. PubMed ID: 23377194
[TBL] [Abstract][Full Text] [Related]
30. The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome.
Polak AM; Krentowska A; Łebkowska A; Buczyńska A; Adamski M; Adamska-Patruno E; Fiedorczuk J; Krętowski AJ; Kowalska I; Adamska A
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32927680
[TBL] [Abstract][Full Text] [Related]
31. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
32. Associations between pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in women with polycystic ovary syndrome.
Zhang L; Zheng W; Liu C; Liang X; Zhang L; Tian Z; Li G
Diabetol Metab Syndr; 2020; 12():88. PubMed ID: 33062059
[TBL] [Abstract][Full Text] [Related]
33. Residential greenness and air pollution concerning excessive gestational weight gain during pregnancy: A cross-sectional study in Wuhan, China.
Wang M; Wen C; Qi H; Xu K; Wei M; Xia W; Lv L; Duan Z; Zhang J
Environ Res; 2023 Jan; 217():114866. PubMed ID: 36427642
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP
Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149
[TBL] [Abstract][Full Text] [Related]
35. Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
Lepine S; Jo J; Metwally M; Cheong YC
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183
[TBL] [Abstract][Full Text] [Related]
36. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.
Dodd JM; Grivell RM; Deussen AR; Hague WM
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010564. PubMed ID: 30039871
[TBL] [Abstract][Full Text] [Related]
37. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
[TBL] [Abstract][Full Text] [Related]
38. The presence of polycystic ovary syndrome increases the risk of maternal but not neonatal complications in women with type 2 diabetes in pregnancy.
Atkins P; Tomlinson G; Feig DS;
Diabetes Metab Res Rev; 2024 Jan; 40(1):e3713. PubMed ID: 37679943
[TBL] [Abstract][Full Text] [Related]
39. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
Pekhlivanov B; Mitkov M; Orbtsova M; Terzieva D
Akush Ginekol (Sofiia); 2008; 47(3):15-9. PubMed ID: 18756827
[TBL] [Abstract][Full Text] [Related]
40. [Association between levels of serum leptin and insulin resistance in patients with polycystic ovary syndrome].
Cheng X; Guo J; Xie J
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1389-91. PubMed ID: 25623461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
